Characterization of CD56+ Dendritic-Like Cells: A Normal Counterpart of Blastic Plasmacytoid Dendritic Cell Neoplasm?

Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities

(2012) J. Tel et al.   BLOOD

Blastic Plasmacytoid Dendritic Cell Neoplasm Expressing the CD13 Myeloid Antigen

(2011) Daichi Inoue et al.   ACTA HAEMATOLOGICA

Circulating plasmacytoid dendritic cells in patients with primary and Helicobacter pylori-associated immune thrombocytopenia

(2011) Akio Saito et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Cutaneous accumulation of plasmacytoid dendritic cells associated with acute myeloid leukemia: a rare condition distinct from blastic plasmacytoid dendritic cell neoplasm

(2011) Jean-Louis Dargent et al.   JOURNAL OF CUTANEOUS PATHOLOGY

IL-2 Costimulation Enables Statin-Mediated Activation of Human NK Cells, Preferentially through a Mechanism Involving CD56+ Dendritic Cells

(2010) G. Gruenbacher et al.   CANCER RESEARCH

The Transcription Factor PU.1 Controls Dendritic Cell Development and Flt3 Cytokine Receptor Expression in a Dose-Dependent Manner

(2010) Sebastian Carotta et al.   IMMUNITY

Transformation of dendritic cells from plasmacytoid to myeloid in a leukemic plasmacytoid dendritic cell line (PMDC05)

(2010) Norihiro Watanabe et al.   LEUKEMIA RESEARCH

Plasmacytoid Dendritic Cell Leukemia with Potent Antigen-Presenting Ability

(2008) Miwako Narita et al.   ACTA HAEMATOLOGICA

Novel markers of normal and neoplastic human plasmacytoid dendritic cells

(2008) T. Marafioti et al.   BLOOD

Identification of CD123+ myeloid dendritic cells as an early-stage immature subset with strong tumoristatic potential

(2008) Jun Shi et al.   CANCER LETTERS

Development of human plasmacytoid dendritic cells depends on the combined action of the basic helix-loop-helix factor E2-2 and the Ets factor Spi-B

(2008) Maho Nagasawa et al.   EUROPEAN JOURNAL OF IMMUNOLOGY